Homologation
increasing compounds by a constant unit;
Chain Brancing
pharmacological changes; lowers potency if lipophilicity is important or could change activity; could interfere with receptor binding
Bioisosterism
substituents or groups with chemical or physical similarities that produce similar biological properties; can attenuate toxicity, modify activity of lead, or alter pharmacokinetics of lead
classic bioisosteres
peripheral layer of electrons are considered identical
non-classic bioisosteres
do not have the same number of atoms; do not fit steric/electronic rules of classic isosteres